Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 3 |
List of Tables | 3 | 1 |
List of Figures | 4 | 1 |
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
BioMarin Pharmaceutical Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 6 | 1 |
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 8 | 1 |
BioMarin Pharmaceutical Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
BioMarin Pharmaceutical Inc., Medical Equipment, Deal Details | 10 | 10 |
Partnerships | 10 | 1 |
Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay | 10 | 1 |
Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay | 11 | 1 |
Equity Offering | 12 | 1 |
BioMarin Pharma Prices Public Offering of Shares for USD720 Million | 12 | 2 |
BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million | 14 | 1 |
Debt Offering | 15 | 1 |
BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million | 15 | 2 |
BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million | 17 | 2 |
Acquisition | 19 | 1 |
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion | 19 | 1 |
BioMarin Pharmaceutical Inc. - Key Competitors | 20 | 1 |
Key Employees | 21 | 2 |
Locations And Subsidiaries | 23 | 2 |
Head Office | 23 | 1 |
Other Locations &Subsidiaries | 23 | 2 |
Recent Developments | 25 | 1 |
Strategy And Business Planning | 25 | 1 |
Sep 30, 2015: Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical PTC Therapeutics, and Sarepta Therapeutics | 25 | 1 |
Financial Announcements | 26 | 1 |
Apr 28, 2016: BioMarin Announces First Quarter 2016 Financial Results | 26 | 2 |
Feb 25, 2016: BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results | 28 | 2 |
Aug 03, 2015: BioMarin Announces Second Quarter 2015 Financial Results and Company Update | 30 | 2 |
Apr 30, 2015: BioMarin Announces First Quarter 2015 Financial Results and Company Update | 32 | 2 |
Feb 25, 2015: BioMarin Announces Fourth Quarter and Full Year 2014 Financial Results | 34 | 2 |
Corporate Communications | 36 | 1 |
Jul 18, 2016: BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg | 36 | 2 |
Jan 04, 2016: BioMarin Announces Addition of David Pyott, Former Allergan Chairman and CEO, to Company's Board of Directors | 38 | 1 |
Jan 07, 2015: BioMarin Announces Planned Changes to Board of Directors Leadership Structure | 39 | 1 |
Appendix | 40 | 1 |
Methodology | 40 | 1 |
About GlobalData | 40 | 1 |
Contact Us | 40 | 1 |
Disclaimer | 40 | 1 |